Zasya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-06-2024
- Paid Up Capital ₹ 0.50 M
as on 28-06-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 28-06-2024
About Zasya Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Ramaswamy Akula, Siddhanand Padukone, Ramakrishna Guduru, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100GJ2021PTC126759
- Company No.
126759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zasya Life Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirav Trivedi  | Director | 13-Jan-2022 | Current |
| Ramaswamy Akula | Whole-Time Director | 26-Oct-2021 | Current |
| Siddhanand Padukone | Director | 13-Jan-2022 | Current |
| Ramakrishna Guduru | Director | 13-Jan-2022 | Current |
| Dilip Chaudhary | Whole-Time Director | 26-Oct-2021 | Current |
Financial Performance of Zasya Life Sciences.
Enhance accessibility to Zasya Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zasya Life Sciences?
Unlock access to Zasya Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Neovant Therapeutics Private LimitedActive 1 year 9 months
Ramakrishna Guduru, Nirav Trivedi and 1 more are mutual person
- Clinoquent Research Private LimitedActive 1 year 4 months
Nirav Trivedi and Dilip Chaudhary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Mar 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Zasya Life Sciences?
Zasya Life Sciences has a workforce of 39 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zasya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zasya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
